Cba Florida, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 14, 2019 at 05:11 pm EST
Share
CBA Florida, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was USD 197,642 compared to USD 297,424 a year ago. Net loss was USD 126,252 compared to USD 93,543 a year ago. For the nine months, operating loss was USD 449,696 compared to USD 1.489 million a year ago. Net loss was USD 210,911 compared to net income of USD 13.731 million a year ago.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC.